Home » AGEB Journal » Issues » Volume 81" » Fasc.3 - Case reports » Article details

Cytomegalovirus pleuropericarditis after orthotopic liver transplantation

Journal Volume 81 - 2018
Issue Fasc.3 - Case reports
Author(s) J. Meesters, L. Beckers, S. Francque, G. Roeyen, K. De Greef, V. Hartman, P. Michielsen, K. Dams, T. Vanwolleghem
Full article
Full Article
VIEW FREE PDF
(1) Antwerp University Hospital, Department of Gastroenterology and Hepatology ; (2) Laboratory of Experimental Medicine and Pediatrics, University of Antwerp ; (3) Antwerp University Hospital, Department of Hepatobiliary Surgery ; (4) Antwerp University Hospital, Department of Intensive Care.

Cytomegalovirus (CMV) reactivation is a common complication after liver transplantation. In patients with CMV infection, indicated by a positive CMV DNA titer, the presence of any clinical symptom is termed CMV disease. The most common organ affected in CMV disease is the gastrointestinal tract, causing esophagitis, gastritis, enteritis or colitis. CMV infection of the pleura and pericard has been reported in immunocompromised patients, but is rarely seen following liver transplantation.We report a case of a 59-year-old male who developed CMV pleuropericarditis after liver transplantation. Initial ganciclovir treatment did not improve the patient's symptoms and therapy was switched to Foscarnet which ultimately resulted in resolution of infection. However, a few weeks after Foscarnet cessation, the patient again developed bilateral pleural effusion. Ultimate biochemical and clinical response was achieved with IV ganciclovir treatment. The patient was discharged from the hospital with oral Valganciclovir for 3 weeks and has since remained relapse free for >1 year. (Acta gastroenterol. belg., 2018, 81, 427-429).

© Acta Gastro-Enterologica Belgica.
PMID 30350533